Synergistic anti-tumor effects of mRNA vaccine and PERK inhibitor combination in melanoma treatment.
Li X, Ma L, Guo J, Wei Y, Ma S, Mai Y, Gou G, Zuo W, Yang J.
Colloids Surf B Biointerfaces · journal article · DOI 10.1016/j.colsurfb.2025.114808 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för gardiquimod. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
26 träffarMolecular characterization and immune role of TLR7 in <i>Labeo rohita</i>.
Pani S, Ganguly B, Mahapatra S, Dash SP, Das R, Saha A, Samanta M.
Front Immunol · research-article; journal article · DOI 10.3389/fimmu.2025.1555048A female-biased gene expression signature of dominance in cooperatively breeding meerkats.
Campbell CR, Manser M, Shiratori M, Williams K, Barreiro L, Clutton-Brock T, Tung J.
Mol Ecol · research support, non-u.s. gov't; research-article; research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.1111/mec.17467Immune Effects of Cryoablation in Woodchuck Hepatocellular Carcinoma.
Mauda-Havakuk M, Hawken NM, Owen JW, Mikhail AS, Starost MF, Karim B, Wakim PG, Franco-Mahecha OL, Lewis AL, Pritchard WF, Karanian JW, Wood BJ.
J Hepatocell Carcinoma · research-article; journal article · DOI 10.2147/jhc.s426442Differential immunophenotype of circulating monocytes from pregnant women in response to viral ligands.
Farias-Jofre M, Romero R, Xu Y, Levenson D, Tao L, Kanninen T, Galaz J, Arenas-Hernandez M, Liu Z, Miller D, Bhatti G, Seyerle M, Tarca AL, Gomez-Lopez N.
BMC Pregnancy Childbirth · research-article; journal article · DOI 10.1186/s12884-023-05562-0In vitro characterization of immune modulating drug-eluting immunobeads towards transarterial embolization in cancer.
Negussie AH, Mikhail AS, Owen JW, Hong N, Carlson CJ, Tang Y, Carrow KP, Mauda-Havakuk M, Lewis AL, Karanian JW, Pritchard WF, Wood BJ.
Sci Rep · research support, n.i.h., intramural; research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/s41598-022-26094-1Theranostic Small-Molecule Prodrug Conjugates for Targeted Delivery and Controlled Release of Toll-like Receptor 7 Agonists.
Debnath S, Hao G, Guan B, Thapa P, Hao J, Hammers H, Sun X.
Int J Mol Sci · research-article; journal article · DOI 10.3390/ijms23137160Molecular dynamics simulations reveal the selectivity mechanism of structurally similar agonists to TLR7 and TLR8.
Wang X, Chen Y, Zhang S, Deng JN.
PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0260565Systemic toll-like receptor 9 agonist CpG oligodeoxynucleotides exacerbates aminoglycoside ototoxicity.
Yang CH, Hwang CF, Chuang JH, Lian WS, Wang FS, Yang MY.
Hear Res · journal article · DOI 10.1016/j.heares.2021.108368Induction of Tertiary Phase Epileptiform Discharges after Postasphyxial Infusion of a Toll-Like Receptor 7 Agonist in Preterm Fetal Sheep.
Cho KHT, Fraser M, Xu B, Dean JM, Gunn AJ, Bennet L.
Int J Mol Sci · research-article; journal article · DOI 10.3390/ijms22126593Potential of TLR agonist as an adjuvant in Leishmania vaccine against visceral leishmaniasis in BALB/c mice.
Goyal DK, Keshav P, Kaur S.
Microb Pathog · journal article · DOI 10.1016/j.micpath.2021.105021Interaction of Type 1 Porcine Reproductive and Respiratory Syndrome Virus With <i>In Vitro</i> Derived Conventional Dendritic Cells.
Li Y, Mateu E.
Front Immunol · research support, non-u.s. gov't; research-article; journal article · DOI 10.3389/fimmu.2021.674185Adjuvant effects of TLR agonist gardiquimod admixed with Leishmania vaccine in mice model of visceral leishmaniasis.
Goyal DK, Keshav P, Kaur S.
Infect Genet Evol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.meegid.2021.104947Microvesicles in active lupus nephritis show Toll-like receptor 9-dependent co-expression of galectin-3 binding protein and double-stranded DNA.
Rasmussen NS, Nielsen CT, Nielsen CH, Jacobsen S.
Clin Exp Immunol · research support, non-u.s. gov't; journal article · DOI 10.1111/cei.13569Polydopamine-Mesoporous Silica Core-Shell Nanoparticles for Combined Photothermal Immunotherapy.
Seth A, Gholami Derami H, Gupta P, Wang Z, Rathi P, Gupta R, Cao T, Morrissey JJ, Singamaneni S.
ACS Appl Mater Interfaces · research-article; journal article · DOI 10.1021/acsami.0c10781Transcriptomic profiling of bovine blood dendritic cells and monocytes following TLR stimulation.
Barut GT, Lischer HEL, Bruggmann R, Summerfield A, Talker SC.
Eur J Immunol · research support, non-u.s. gov't; journal article · DOI 10.1002/eji.202048643Hybrid nanovaccine for the co-delivery of the mRNA antigen and adjuvant.
Yang J, Arya S, Lung P, Lin Q, Huang J, Li Q.
Nanoscale · journal article · DOI 10.1039/c9nr05475hIntraperitoneal gardiquimod protects against hepatotoxicity through inhibition of oxidative stress and inflammation in mice with sepsis.
Guo S, Zhang Y, Wang Z, Yu Y, Wang G.
J Biochem Mol Toxicol · journal article · DOI 10.1002/jbt.21923Combining vasculature disrupting agent and Toll-like receptor 7/8 agonist for cancer therapy.
Seth A, Lee H, Cho MY, Park C, Korm S, Lee JY, Choi I, Lim YT, Hong KS.
Oncotarget · research-article; journal article · DOI 10.18632/oncotarget.14260Activation of Toll-like receptor 7 regulates the expression of IFN-λ1, p53, PTEN, VEGF, TIMP-1 and MMP-9 in pancreatic cancer cells.
Wang F, Jin R, Zou BB, Li L, Cheng FW, Luo X, Geng X, Zhang SQ.
Mol Med Rep · research support, non-u.s. gov't; journal article · DOI 10.3892/mmr.2015.4730Gardiquimod inhibits the expression of calcium-induced differentiation markers in HaCaT cells.
Jia B, Luo X, Cheng FW, Li L, Hu DJ, Wang F, Zhang SQ.
Mol Biol Rep · research support, non-u.s. gov't; journal article · DOI 10.1007/s11033-013-2750-9Induction of pro-inflammatory cytokine production in thymocytes by the immune response modifiers Imiquimod and Gardiquimod™.
Weber A, Zimmermann C, Mausberg AK, Kieseier BC, Hartung HP, Hofstetter HH.
Int Immunopharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.intimp.2013.06.023Gardiquimod: a Toll-like receptor-7 agonist that inhibits HIV type 1 infection of human macrophages and activated T cells.
Buitendijk M, Eszterhas SK, Howell AL.
AIDS Res Hum Retroviruses · research-article; journal article · DOI 10.1089/aid.2012.0313The TLR7 agonists imiquimod and gardiquimod improve DC-based immunotherapy for melanoma in mice.
Ma F, Zhang J, Zhang J, Zhang C.
Cell Mol Immunol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/cmi.2010.30Structure-activity relationships in human toll-like receptor 7-active imidazoquinoline analogues.
Shukla NM, Malladi SS, Mutz CA, Balakrishna R, David SA.
J Med Chem · research-article; journal article; research support, n.i.h., extramural · DOI 10.1021/jm100358cPorcine TLR8 and TLR7 are both activated by a selective TLR7 ligand, imiquimod.
Zhu J, Lai K, Brownile R, Babiuk LA, Mutwiri GK.
Mol Immunol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.molimm.2008.02.028